← Leaderboards
Frances E. Lund
University Of Alabama At Birmingham
$38,753,426
Attributed
$38,757,426
Total exposure
23
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,424,642 · 25
By mechanism
U19$43,326,384 · 10
R01$18,746,616 · 10
P01$2,253,168 · 2
G20$671,291 · 1
R21$419,183 · 1
R13$8,000 · 1
Top collaborators
- Nathaniel Bernard Erdmann1 shared
- W Timothy Garvey1 shared
- Paul A. Goepfert1 shared
- James O Hill1 shared
- Myron K Jacobson1 shared
- Troy D Randall1 shared
- Anath Shalev1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Louis B Justement$5,889,194
- Amit Gaggar$7,818,359
- Beatriz Leon Ruiz$3,619,500
- Kaihong Su$1,704,079
- Troy D Randall$33,910,350
Others in their field
Top investigators on “B-Lymphocytes”
- Barton F Haynes · Duke University$400,419,833
- Lawrence Corey · Fred Hutchinson Cancer Center$83,920,398
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
- Dan H. Barouch · Fred Hutchinson Cancer Center$66,039,430
- Dennis R. Burton · Scripps Research Institute$63,566,673
- Rafi Ahmed · Emory University$62,743,001
Research focus
B-LymphocytesCellsTissuesResponseInfectionImmunityImmune ResponseAntibodiesDesignImmuneProgramsPathogenCytokineAntigensPlayMediatingMolecularInfluenzaSignal TransductionMemory B-LymphocyteOrganPropertyT-LymphocyteMaintenance
Grant awards (105)
Evolution and Durability of Human T and B Cell Responses$3,474,901
U19 · FY2025 · AI · contact PI
Core A: Administrative Core$434,363
U19 · FY2025 · AI · contact PI
Project 1: Evolution and Durability of allo(auto)immune B cell responses in organ transplant recipients$434,362
U19 · FY2025 · AI · contact PI
Infrastructure and Opportunity Fund Management Core (IOFMC)$434,362
U19 · FY2025 · AI · contact PI
Evolution and Durability of Human T and B Cell Responses$3,474,901
U19 · FY2024 · AI · contact PI
Infrastructure and Opportunity Fund Management Core (IOFMC)$1,250,964
U19 · FY2024 · AI · contact PI
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination$735,422
R01 · FY2024 · AI · contact PI
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals$713,270
R01 · FY2024 · AI · contact PI
Regulation of T cell responses to allergens and environmental microbes$445,500
R01 · FY2024 · AI · contact PI
Project 1: Evolution and Durability of allo(auto)immune B cell responses in organ transplant recipients$364,253
U19 · FY2024 · AI · contact PI
Control of B cell differentiation by IFNg induced transcription factors$259,967
R01 · FY2024 · AI · contact PI
Core A: Administrative Core$69,499
U19 · FY2024 · AI · contact PI
Tissue and organ specific human B cell immunity$3,552,993
U19 · FY2023 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$1,454,673
U19 · FY2023 · AI · contact PI
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues$945,780
U19 · FY2023 · AI · contact PI
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination$735,422
R01 · FY2023 · AI · contact PI
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals$713,270
R01 · FY2023 · AI · contact PI
Control of B cell differentiation by IFNg induced transcription factors$259,967
R01 · FY2023 · AI · contact PI
Administrative Core$99,273
U19 · FY2023 · AI · contact PI
Tissue and organ specific human B cell immunity$3,556,205
U19 · FY2022 · AI · contact PI
Tissue and organ specific human B cell immunity: Supplement - Metabolic Risk Factors and Inflammation in PASC Development$1,033,284
U19 · FY2022 · AI · contact PI
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals$713,270
R01 · FY2022 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$444,526
U19 · FY2022 · AI · contact PI
Administrative Core$444,526
U19 · FY2022 · AI · contact PI
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues$444,525
U19 · FY2022 · AI · contact PI
Control of B cell differentiation by IFNg induced transcription factors$259,967
R01 · FY2022 · AI · contact PI
Tissue and organ specific human B cell immunity$3,558,962
U19 · FY2021 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$1,336,501
U19 · FY2021 · AI · contact PI
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination$735,422
R01 · FY2021 · AI · contact PI
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals$713,270
R01 · FY2021 · AI · contact PI
Tissue and organ specific human B cell immunity$444,936
U19 · FY2021 · AI · contact PI
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues$415,536
U19 · FY2021 · AI · contact PI
Control of B cell differentiation by IFNg induced transcription factors$259,967
R01 · FY2021 · AI · contact PI
Administrative Core$97,710
U19 · FY2021 · AI · contact PI
Tissue and organ specific human B cell immunity$3,562,534
U19 · FY2020 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$1,330,666
U19 · FY2020 · AI · contact PI
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals$725,395
R01 · FY2020 · AI · contact PI
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination$722,300
R01 · FY2020 · AI · contact PI
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues$444,936
U19 · FY2020 · AI · contact PI
Tissue and organ specific human B cell immunity$444,936
U19 · FY2020 · AI · contact PI
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues$420,143
U19 · FY2020 · AI · contact PI
Control of B cell differentiation by IFNg induced transcription factors$259,967
R01 · FY2020 · AI · contact PI
Administrative Core$108,472
U19 · FY2020 · AI · contact PI
Tissue and organ specific human B cell immunity$3,563,564
U19 · FY2019 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$1,336,500
U19 · FY2019 · AI · contact PI
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues$415,709
U19 · FY2019 · AI · contact PI
Administrative Core$118,127
U19 · FY2019 · AI · contact PI
Control of antiviral-viral B cell responses by IFNy T-bet and Eomes$597,871
U19 · FY2018 · AI · contact PI
Viral Stocks and Reagents$352,918
U19 · FY2018 · AI · contact PI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes$214,452
R01 · FY2018 · AI · contact PI
Control of antiviral-viral B cell responses by IFNy T-bet and Eomes$442,943
U19 · FY2017 · AI · contact PI
Controlling Th2 immunity by tuning CXCL13 dependent DC migration in lymph nodes$367,500
R01 · FY2017 · AI · contact PI
Viral Stocks and Reagents$236,211
U19 · FY2017 · AI · contact PI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes$214,452
R01 · FY2017 · AI · contact PI
Control of antiviral-viral B cell responses by IFNy T-bet and Eomes$651,414
U19 · FY2016 · AI · contact PI
Controlling Th2 immunity by tuning CXCL13 dependent DC migration in lymph nodes$367,500
R01 · FY2016 · AI · contact PI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes$214,452
R01 · FY2016 · AI · contact PI
Viral Stocks and Reagents$187,872
U19 · FY2016 · AI · contact PI
Control of antiviral-viral B cell responses by IFNy T-bet and Eomes$701,261
U19 · FY2015 · AI · contact PI
Controlling Th2 immunity by tuning CXCL13 dependent DC migration in lymph nodes$367,500
R01 · FY2015 · AI · contact PI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes$214,452
R01 · FY2015 · AI · contact PI
Viral Stocks and Reagents$163,118
U19 · FY2015 · AI · contact PI
Evaluation of IFN-gamma-Producing Effector Cells in Infectious and Autoimmune Disease$435,391
P01 · FY2014 · AI · contact PI
Controlling Th2 immunity by tuning CXCL13 dependent DC migration in lymph nodes$367,500
R01 · FY2014 · AI · contact PI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes$321,749
R01 · FY2014 · AI · contact PI
Control of antiviral-viral B cell responses by IFNy T-bet and Eomes$303,830
U19 · FY2014 · AI · contact PI
Viral Stocks and Reagents$176,324
U19 · FY2014 · AI · contact PI
Evaluation of IFNy - Producin Effector Cells in Infectious and Autoimmune Disease$400,101
P01 · FY2013 · AI · contact PI
Controlling Th2 immunity by tuning CXCL13 dependent DC migration in lymph nodes$344,765
R01 · FY2013 · AI · contact PI
Evaluation of IFNy - Producin Effector Cells in Infectious and Autoimmune Disease$427,888
P01 · FY2012 · AI · contact PI
Evaluation of IFNy - Producin Effector Cells in Infectious and Autoimmune Disease$382,638
P01 · FY2011 · AI · contact PI
Generation and Characterization of Human Cytokine-Producing B Cell Effectors$160,164
R21 · FY2011 · AI · contact PI
Generation and Characterization of Human Cytokine-Producing B Cell Effectors$29,269
R21 · FY2011 · AI · contact PI
NAD Metabolism and Signaling$8,000
R13 · FY2011 · CA · contact PI
Evaluation of IFNy - Producin Effector Cells in Infectious and Autoimmune Disease$372,807
P01 · FY2010 · AI · contact PI
NAD and CD38: modulators of inflammation and immunity$336,518
R01 · FY2010 · AI · contact PI
Generation and maintenance of influenza-specific plasma and memory B cells$326,759
R01 · FY2010 · AI · contact PI
Generation and Characterization of Human Cytokine-Producing B Cell Effectors$229,750
R21 · FY2010 · AI · contact PI
Generation and maintenance of influenza-specific plasma and memory B cells$484,594
R01 · FY2009 · AI · contact PI
NAD and CD38: modulators of inflammation and immunity$339,917
R01 · FY2009 · AI · contact PI
Generation and maintenance of influenza-specific plasma and memory B cells$330,059
R01 · FY2009 · AI · contact PI
Generation and maintenance of influenza-specific plasma and memory B cells$274,967
R01 · FY2008 · AI · contact PI
NAD and CD38: modulators of inflammation and immunity$257,180
R01 · FY2008 · AI · contact PI
NAD and CD38: modulators of inflammation and immunity$135,711
R01 · FY2008 · AI · contact PI
Generation and maintenance of influenza-specific plasma and memory B cells$100,100
R01 · FY2008 · AI · contact PI
NAD and CD38: modulators of inflammation and immunity$400,500
R01 · FY2007 · AI · contact PI
Generation and maintenance of influenza-specific plasma and memory B cells$382,331
R01 · FY2007 · AI · contact PI
Generation and maintenance of influenza-specific plasma and memory B cells$393,750
R01 · FY2006 · AI · contact PI
Ecto-enzyme CD38: Regulator of dendritic cell migration$341,775
R01 · FY2006 · AI · contact PI
Regulation of immune reponses by B cell cytokines$337,869
R01 · FY2006 · AI · contact PI
Ecto-enzyme CD38: Regulator of dendritic cell migration$350,000
R01 · FY2005 · AI
Regulation of immune reponses by B cell cytokines$346,000
R01 · FY2005 · AI
Core--Animal resources$87,454
P01 · FY2005 · HL
Ecto-enzyme CD38: Regulator of dendritic cell migration$350,000
R01 · FY2004 · AI
Regulation of immune reponses by B cell cytokines$346,000
R01 · FY2004 · AI
Core--Animal resources$146,889
P01 · FY2004 · HL
Regulation of immune reponses by B cell cytokines$346,000
R01 · FY2003 · AI
ROLE FOR THE ECTOENZYME CD38 IN IMMUNE RESPONSES$256,140
R01 · FY2003 · AI
Regulation of immune reponses by B cell cytokines$346,000
R01 · FY2002 · AI
ROLE FOR THE ECTOENZYME CD38 IN IMMUNE RESPONSES$248,679
R01 · FY2002 · AI
Core--Animal resources$0
P01 · FY2002 · HL
DEVELOPING AND IMPROVING INSTITUTIONAL ANIMAL RESOURCES$671,291
G20 · FY2001 · RR
ROLE FOR THE ECTOENZYME CD38 IN IMMUNE RESPONSES$241,437
R01 · FY2001 · AI
Core--Animal resources$0
P01 · FY2001 · HL
ROLE FOR THE ECTOENZYME CD38 IN IMMUNE RESPONSES$227,632
R01 · FY2000 · AI